Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours

Abstract

Diffuse oesophageal leiomyomatosis (DL), an inherited smooth muscle proliferation process, has been reported to be associated with Alport syndrome (AS), a familial nephropathy, mainly dominant X-linked inherited, and characterized by ultrastructural changes of the glomerular basement membrane. The COL4A5 gene, encoding the α5 chain of type IV collagen, has been identified as the site of mutations in families with X-linked AS. Recently, a novel α6(IV) collagen chain encoding gene has been mapped closely upstream of COL4A5, and disruption of the 5′ end of both genes has been reported in four patients with DL and AS (DL — AS). Here, we report a long-range restriction map around the COL4A6 locus, and show that the COL4A5/COL4A6 deletion observed in seven patients with DL—AS encompasses only the two first exons of COL4A6, with a breakpoint located in the second intron of COL4A6, whose size exceeds 65 kb. Furthermore, we demonstrate that three patients with AS without DL, known to have a deletion of the 5′ part of the COL4A5 gene, display a larger deletion in COL4A6. Moreover, a COL4A6 mRNA product was detected by reverse-transcription—polymerase chain reaction in an oesophageal tumour sample of a patient with DL—AS. These results suggest that DL—AS could be caused by an abnormal truncated α6(IV) chain.